For example, phosphorylation at the AT8 epitope colocalizes with PAD exposure and oligomeric tau in AD, and phosphomimetics at sites within the AT8 epitope causes PAD exposure and impair axonal transport (46, 51, 55, 61, 62, 63). This evidence concerns the gene MAPT and Alzheimer disease.